AAF
AZN icon

Andra AP-fonden’s AstraZeneca AZN Stock Holding History

Andra AP-fonden’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$347M Buy
+236,302
New +$45.6M 4.14% 4

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Andra AP-fonden's AZN Position: Q1 2026 in Review

Andra AP-fonden opened a new position in AstraZeneca (AZN) in Q1 2026: 236,302 shares worth $347M. The stake represents 4.14% of the portfolio and ranks #4 among its holdings.

1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Andra AP-fonden held 236,302 shares of AstraZeneca worth $347M as of Q1 2026.
  • AstraZeneca was a new Andra AP-fonden position in Q1 2026.
  • AstraZeneca made up 4.14% of Andra AP-fonden's portfolio in Q1 2026, its #4 holding.
  • 1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.